Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim A Julian

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Registries that show efficacy: good, but not good enoughMark N Levine, Jim A Julian
Annals of Internal Medicine|May 5, 2015
D-Dimer Testing in Patients With a First Unprovoked Venous ThromboembolismClive Kearon, Scott M Stevens, Jim A Julian
Lancet (London, England)|July 12, 2005
Deep vein thrombosisClive Kearon, Michael J Kovacs, Jim A Julian
Blood|March 23, 2006
Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-upDonald M Arnold, Jim A Julian, Irwin R Walker, et al.
Thrombosis and Haemostasis|November 5, 2005
Significant association with location of central venous line placement and risk of venous thrombosis in childrenChristoph Male, Jim A Julian, Patricia Massicotte, et al.
Springerplus|July 15, 2014
Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified timesSameer Parpia, Jim A Julian, Chushu Gu, et al.
BMC Medical Research Methodology|March 23, 2013
Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer studySameer Parpia, Lehana Thabane, Jim A Julian, et al.
Thrombosis and Haemostasis|August 4, 2017
Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolismSarah Takach Lapner, Jim A Julian, Lori-Ann Linkins, et al.
Thrombosis Research|December 14, 2002
In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulationLori Ann Linkins, Jim A Julian, Janice Rischke, et al.
Journal of Oncology Practice|December 12, 2013
Cost effectiveness of a survivorship care plan for breast cancer survivorsDoug Coyle, Eva Grunfeld, Kathryn Coyle, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Registries that show efficacy: good, but not good enoughMark N Levine, Jim A Julian
Annals of Internal Medicine|May 5, 2015
D-Dimer Testing in Patients With a First Unprovoked Venous ThromboembolismClive Kearon, Scott M Stevens, Jim A Julian
Lancet (London, England)|July 12, 2005
Deep vein thrombosisClive Kearon, Michael J Kovacs, Jim A Julian
Blood|March 23, 2006
Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-upDonald M Arnold, Jim A Julian, Irwin R Walker, et al.
Thrombosis and Haemostasis|November 5, 2005
Significant association with location of central venous line placement and risk of venous thrombosis in childrenChristoph Male, Jim A Julian, Patricia Massicotte, et al.
Springerplus|July 15, 2014
Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified timesSameer Parpia, Jim A Julian, Chushu Gu, et al.
BMC Medical Research Methodology|March 23, 2013
Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer studySameer Parpia, Lehana Thabane, Jim A Julian, et al.
Thrombosis and Haemostasis|August 4, 2017
Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolismSarah Takach Lapner, Jim A Julian, Lori-Ann Linkins, et al.
Thrombosis Research|December 14, 2002
In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulationLori Ann Linkins, Jim A Julian, Janice Rischke, et al.
Journal of Oncology Practice|December 12, 2013
Cost effectiveness of a survivorship care plan for breast cancer survivorsDoug Coyle, Eva Grunfeld, Kathryn Coyle, et al.
Pageof 8